IoNIR
Coronary artery disease
InvestigationalActive
Key Facts
About Medinol
Innovative cardiovascular device maker with CE‑approved drug‑eluting stents and emerging implantable sensor platform.
View full company profileTherapeutic Areas
Other Coronary artery disease Drugs
| Drug | Company | Phase |
|---|---|---|
| MUTI™ Drug‑Eluting Stent | Meril | Commercial |
| Coronary Artery Bypass Grafts | Vascudyne | Pre-clinical |
| Premier DES | Relisys Medical Devices | Commercial |
| Release R DES | Relisys Medical Devices | Commercial |
| Pristine DES | Relisys Medical Devices | Commercial |
| BioMatrix family (Flex/Alpha) | Biosensors International | Commercial |
| Coronary Artery Disease Program | Elixir Medical | Pre-clinical |
| Essential pro Stent | iVascularU | Post-Market |
| FGF-1 | Zhittya Genesis Medicine | Phase 2 |
| OMT-28 | OMEICOS Therapeutics | Phase 2 |
| Fantom Encore | REVA Medical | Commercial |
| Next-Gen Drug-Eluting Stents | Translumina | Development |